Quantum Biopharma Ltd. (QNTM) Enterprise Value (2018 - 2026)

Quantum Biopharma (QNTM) has 9 years of Enterprise Value data on file, last reported at -$6.6 million in Q1 2026.

• Quarterly Enterprise Value fell 38.74% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.6 million (down 38.74% YoY) and the FY2025 annual result came in at -$4.2 million, up 49.19% from the prior year.
• Enterprise Value declined to -$6.6 million in Q1 2026 per QNTM's latest filing, from -$4.2 million in the prior quarter.
• The five-year high for Enterprise Value was -$2.2 million in Q3 2025, with the low at -$32.0 million in Q2 2022.
• Average Enterprise Value over 5 years is -$10.9 million, with a median of -$6.6 million recorded in 2026.
• Year-over-year, Enterprise Value soared 81.49% in 2023 and sank 69.17% in 2024.
• Quantum Biopharma's Enterprise Value stood at -$17.0 million in 2022, then soared by 73.72% to -$4.5 million in 2023, then plunged by 84.59% to -$8.2 million in 2024, then soared by 49.19% to -$4.2 million in 2025, then sank by 57.18% to -$6.6 million in 2026.
• Business Quant data shows QNTM's Enterprise Value at -$6.6 million in Q1 2026, -$4.2 million in Q4 2025, and -$2.2 million in Q3 2025.